Judge deems antitrust suit to be outside arbitration
A federal district court has ruled Johnson & Johnson and Janssen Biotech cannot force individual arbitration of antitrust claims brought by a class of direct purchasers of Remicade.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10